← Back to Search

Behavioral Intervention

Digital Health Program for Post-COVID Syndrome (LIGHT Trial)

N/A

Waitlist Available

Led By Kirsten Langdon, PhD

Research Sponsored by Rhode Island Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis (self-reported) of COVID-19

Must be over 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks

Awards & highlights

LIGHT Trial Summary

This trial will test a 4-week program to help 10 people with long-term COVID symptoms. Participants will be assessed and interviewed before and after the program and compensated for their time.

Who is the study for?

This trial is for adults over 18 who have self-reported Long COVID symptoms and a past diagnosis of COVID-19. Participants must own a device capable of texting and speak English well enough to give informed consent.Check my eligibility

What is being tested?

The iENDURE program, aimed at improving distress tolerance in individuals with Long COVID, is being tested. It involves a baseline assessment, a 4-week intervention period using digital health technology, followed by another assessment and interview.See study design

What are the potential side effects?

Since this trial involves the use of digital health technology rather than medication, traditional side effects are not expected. However, participants may experience discomfort or emotional distress while engaging with the content.

LIGHT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with COVID-19.

Select...

I am over 18 years old.

LIGHT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Client Satisfaction Score (CSQ-8)

System Usability Score (SUS)

LIGHT Trial Design

1Treatment groups

Experimental Treatment

Group I: distress tolerance skills trainingExperimental Treatment1 Intervention

technology delivered distress tolerance skills training

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

iENDURE

2020

N/A

~80

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor

260 Previous Clinical Trials

66,997 Total Patients Enrolled

Brown UniversityOTHER

456 Previous Clinical Trials

558,344 Total Patients Enrolled

Kirsten Langdon, PhDPrincipal InvestigatorBrown University

1 Previous Clinical Trials

80 Total Patients Enrolled

Media Library

iENDURE (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05616806 — N/A

Distress Tolerance Research Study Groups: distress tolerance skills training

Distress Tolerance Clinical Trial 2023: iENDURE Highlights & Side Effects. Trial Name: NCT05616806 — N/A

iENDURE (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05616806 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to enroll in this investigation at the current time?

"The trial specifics on clinicaltrials.gov indicate that this medical test is not currently recruiting patients; the first post was made on November 15th 2022 and the last update was issued a few days later. Despite its inactivity, there are 23 other trials actively looking for participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Long COVID-19 Intervention Using Digital Health & Technology

2023. "Long COVID-19 Intervention Using Digital Health & Technology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05616806.

All > Survivor Corps